Humanized mouse modelHumanized mice s brandHumanized mice,PharmaLegacy_specification/price/image

Product Detail
Company Profile

   PharmaLegacy Laboratories (Shanghai) Co., Ltd was founded in 10 years ago, After a period of rapid development, it has developed into a considerable size and effectiveness company of Humanized miceandSyngeneic mouse model, NOw it is benchmark companies in 商务服务,医疗服务,医疗保健 industry.

   Innovation is the cornerstones of PharmaLegacy Laboratories (Shanghai) Co., Ltds success. In the future, PharmaLegacy also hope to continue to innovate, for the majority of customers to provide Non-Human Primates modelsx2a38631nservice. Over the years, PharmaLegacy always believe that only adhere to innovation and professional, in order to better meet customer demand for humanized mouse model for malaria anemia research paper. details:Humanized mice are a robust in vivo platform for analyzing the safety and effectiveness of potential new drugs to modulate the immune system. Humanized mice are supreme in vivo models for long-term studies in the fields of immuno-oncology, infectious disease, and graft versus host disease. Humanized mouse model engrafted with cord blood-derived hematopoietic stem cells (HSC) develop a functional human immune system and display robust T-cell maturation and T-cell dependent inflammatory responses. Large cohorts of humanized mice are available for immediate delivery or to enroll in drug efficacy testing services.

Adhering to the "Customer Supreme Forge Ahead" management idea, PharmaLegacy insists on providing the best quality and service of Non-Human Primates models,Rheumatoid arthritis Model with the "customer first" principle. Wholeheartedly welcome your patronage! Official website address: www.pharmalegacy.com

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings